Outcomes and GRADE Summary of Findings Tables: old and new

Similar documents
Washington, DC, November 9, 2009 Institute of Medicine

'Summary of findings' tables in network meta-analysis (NMA)

Update on bronchiectasis guidelines. James Chalmers MD, PhD, FRCPE, FERS University of Dundee, UK

Cochrane-GRADE Workshop

Copyright GRADE ING THE QUALITY OF EVIDENCE AND STRENGTH OF RECOMMENDATIONS NANCY SANTESSO, RD, PHD

GRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2014

GRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2018

ACR OA Guideline Development Process Knee and Hip

DO CLINICIANS WANT RECOMMENDATIONS? A RANDOMIZED TRIAL. On behalf of Ignacio Neumann & the group of authors

Why is ILCOR moving to GRADE?

SOF: Summary of Findings tables. Negrar, 7 aprile 2018

Reporting the effects of an intervention in EPOC reviews. Version: 21 June 2018 Cochrane Effective Practice and Organisation of Care Group

Objectives. Information proliferation. Guidelines: Evidence or Expert opinion or???? 21/01/2017. Evidence-based clinical decisions

Results. NeuRA Hypnosis June 2016

Incorporating qualitative research into guideline development: the way forward

Traumatic brain injury

The Joanna Briggs Institute Reviewers Manual 2014

NeuRA Sleep disturbance April 2016

Problem solving therapy

GRADE, Summary of Findings and ConQual Workshop

Workshop: Cochrane Rehabilitation 05th May Trusted evidence. Informed decisions. Better health.

Results. NeuRA Worldwide incidence April 2016

JBI GRADE Research School Workshop. Presented by JBI Adelaide GRADE Centre Staff

Determinants of quality: Factors that lower or increase the quality of evidence

Introduzione al metodo GRADE

Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS

PGY1 Learning activities-ebcp Scripts

Results. NeuRA Treatments for internalised stigma December 2017

Database of treatment effects user guide

Results. NeuRA Mindfulness and acceptance therapies August 2018

Results. NeuRA Herbal medicines August 2016

Mapping from SORT to GRADE. Brian S. Alper, MD, MSPH, FAAFP Editor-in-Chief, DynaMed October 31, 2013

AXIS critical Appraisal of cross sectional Studies

NCCN Clinical Practice Guidelines Development Process

Results. NeuRA Forensic settings April 2016

Animal-assisted therapy

Distraction techniques

AUTHORS GUIDE TO GRADE

Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE

Comparative Effectiveness Research Collaborative Initiative (CER-CI) PART 1: INTERPRETING OUTCOMES RESEARCH STUDIES FOR HEALTH CARE DECISION MAKERS

Results. NeuRA Treatments for dual diagnosis August 2016

Results. NeuRA Family relationships May 2017

TVN Webinar Series Wednesday, October 21, 2015

Influenza virus infections result in major health and economic. Review

Transcranial Direct-Current Stimulation

Measuring the impact of patient and public involvement in the JLA Kidney Transplant PSP

Glossary of Practical Epidemiology Concepts

Establishing confidence in qualitative evidence. The ConQual Approach

NeuRA Obsessive-compulsive disorders October 2017

Madhukar Pai, MD, PhD Associate Professor Department of Epidemiology & Biostatistics McGill University, Montreal, Canada

Sabbatical Experience World Health Organization

Systematic reviews: From evidence to recommendation. Marcel Dijkers, PhD, FACRM Icahn School of Medicine at Mount Sinai

CEU screening programme: Overview of common errors & good practice in Cochrane intervention reviews

Method. NeuRA Paliperidone August 2016

Method. NeuRA Biofeedback May 2016

Results. NeuRA Motor dysfunction April 2016

Clinical Practice Guideline for PTSD: An Overview of the Process and the Product Featuring APA Staff Psychologist Lynn Bufka, PhD

Clinical Epidemiology for the uninitiated

Psychological therapies for people with dementia who have associated depression [New 2015].

Cochrane Update Assessing evidence in public health: the added value of GRADE

Lorne A. Becker MD Emeritus Professor SUNY Upstate Medical University. Co-Chair, Cochrane Collaboration Steering Group

Webinar 3 Systematic Literature Review: What you Need to Know

Background. Population/Intervention(s)/Comparator/Outcome(s) (PICO) Duration of antipsychotic treatment in individuals with a first psychotic episode

Standards for the reporting of new Cochrane Intervention Reviews

NeuRA Decision making April 2016

Cochrane Breast Cancer Group

Authors face many challenges when summarising results in reviews.

Evidence profile. Physical Activity. Background on the scoping question. Population/Intervention/Comparison/Outcome (PICO)

Alcohol interventions in secondary and further education

Essential Skills for Evidence-based Practice: Statistics for Therapy Questions

Background. Population/Intervention(s)/Comparison/Outcome(s) (PICO) Role of antidepressants in people with dementia and associated depression

Grading the Evidence Developing the Typhoid Statement. Manitoba 10 th Annual Travel Conference April 26, 2012

Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies

NeuRA Schizophrenia diagnosis May 2017

Panel 2 What Does, What Could and What Should Count as Research Use? The right kind of evidence integrating, measuring and making it count

Effective Health Care Program

EARLY DISEASE DETECTION. Sampling principles. Why use apparently healthy animals. Random Sampling. Traditional approaches to Diagnosis & Prognosis

INTRODUCTION WHAT ARE PROFESSIONAL SOCIETIES AND OTHER ORGANIZATIONS DOING NOW?

Official ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis

Post-traumatic stress disorder

Results. NeuRA Essential fatty acids August 2016

Practice guidelines : overview of methodology with focus on GRADE

The Post Stroke Checklist

The Cochrane Collaboration, the US Cochrane Center, and The Cochrane Library

Clinical Decision Support Technologies for Oncologic Imaging

How to incorporate Patient- Reported Outcomes (PROs) in Cochrane reviews? Caroline Terwee, Donald Patrick, Gordon Guyatt, Riekie de Vet

TNF-alpha inhibitors for ankylosing spondylitis(review)

The Cochrane Collaboration

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Essential Skills for Evidence-based Practice Understanding and Using Systematic Reviews

Online Annexes (5-8)

Evidence Based Medicine

Method. NeuRA Cholinesterase inhibitors August 2016

Background: Traditional rehabilitation after total joint replacement aims to improve the muscle strength of lower limbs,

G-I-N North America Webinars

Year Area Grade 1/2 Grade 3/4 Grade 5/6 Grade 7+ K&U Recognises basic features of. Uses simple models to explain objects, living things or events.

Revman Plots: Glucose child up to 2 yrs Distress Acute

RECOMMENDATIONS FOR GROWTH MONITORING, PREVENTION AND MANAGEMENT OF OVERWEIGHT AND OBESITY IN CHILDREN AND YOUTH IN PRIMARY HEALTH CARE 2015

BEST in MH clinical question-answering service

Does the evidence directly answer my question?

Transcription:

Holger Schünemann, MD, PhD Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Clinical Epidemiology & Biostatistics and of Medicine Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada @schunemann_mac COMET meeting, Rome, November 19 2014 Outcomes and GRADE Summary of Findings Tables: old and new

Disclosure Co-chair GRADE Working Group World Health Organization: various committees Co-director, WHO collaborating center on evidence informed policy making Cochrane Collaboration Steering group GIN Board of Directors No direct financial COI

C Summary of Findings Tables Prior work Updates ontent

Evidence profiles Question and source of evidence (systematic review) Population, intervention, comparator, outcomes Outcomes Methds and evaluation Effect estimates Confidence/quality by outcome: High Moderate Low Very low

First study of SoF Number of outcomes 7 Presenting information on all important outcomes; ordering of outcomes 20 Cochrane review authors participated (20 new or updated reviews) spent an additional 4 h (2 to 40 h) layout clear 11/17 increased accessibility 5/17 improved quality 1/17 rephrased conclusions

RCTs RCTs 1 EBCP workshop (N 72); 2 Cochrane entities meeting (N 33) RCT 1: easy to find results, SoF versus no: 68 vs. 40% (p = 0.02) RCT 2: SoF more correct answers to two questions re results 93% vs 44% (p = 0.003) and 87% vs. 11% (p < 0.001) SoF participants spent average of 90 seconds to find key information vs 4 minutes without SoF table

134 fewer 22 fewer 5 more

Optimal format Evidence Profiles RCT alternative testing formats of Evidence Profiles in 88 guideline panelists Preferences for: Study event rates over no (small/moderate effect) Absolute risk differences over absolute risks (large effect) more likely to correctly interpret CI around difference (58 vs 11%, p < 0.0001) Information in table cells vs footnotes (small/moderate effect) In cells more likely to get time frame right (58% vs 11%, p < 0.0001) Information EP judged easy to find, comprehend, helpful both (median 6 of 7)

C Summary of Findings Tables Prior work Updates ontent

Cochrane method innovation fund project Enhancing the acceptance and implementation of SoF tables in Cochrane reviews Initiated in 2012 Feedback from Cochrane review groups User-testing of potential solutions Formal testing of formats RCT

Enhancing the acceptance and implementation of SoF tables in 40 participants Cochrane reviews Cochrane review users (clinicians, guideline developers, researchers) Participants prefer simple, less crowded SoF tables Dichotomous: NNTs, Risk Difference over natural frequencies Continuous: Minimal important difference units over MD and SMD what happens column: statement of presence/direction of effect and qualitative statement of confidence U ser testing

Table 1. Comparison between items included in the current and alternative SoF tables formats Current formats (Table B) Alternative formats (Table A) 1 Inclusion of the Nº of participants and studies column Exclusion of the Nº of participants and studies column. Information presented in the outcomes column 2 Quality of evidence presented with symbols and labeled as High, moderate, low, or very low. Reasons for downgrading presented in the footnotes Quality of evidence presented with main reasons for downgrading in the same column (e.g. MODERATE due to imprecision) 3 Footnotes label Explanations label 4 Baseline risk and corresponding risk expressed as natural frequencies Baseline risk and corresponding risk expressed as percentages 5 No column presenting absolute risk reduction (risk difference) or mean difference Inclusion of a column presenting absolute risk reduction (risk difference) or mean difference 6 Comments column included Comments column deleted 7 No what happens column* What happens column included* 8 Description of the GRADE Working Group grades of evidence definitions below the table No description of the GRADE Working Group grades of evidence definitions

300 Clinicians, guideline developers, researchers Alternative vs current formats Understanding, accessibility, satisfaction, preference R CT Design

R Percentage of participants that answered correctly understanding questions Concept Ability to determine risk difference Understanding of quality of evidence and treatment effect Question asked How many fewer children < 5 years will have diarrhea if they have probiotics than if they do not? Which of the following statements best represents the results informing the outcome adverse events? Alternative formats (N=122) Current formats (N=168) Difference P value 98% 35% 63% <0.001 88% 26% 62% <0.001 CT Results

DECIDE: Interactive Summary of Findings tables

Diagnostic SoF Tables

Testing of different entry points

Multiple comparisons

www.gradepro.org

Tools

Why is this relevant for COMET Summary of Findings Tables report information for patient or population important outcomes Outcomes are determined by decisionmakers (e.g. panels): over and over again

Grade up Grade down Randomization raises initial quality RCTs: high Observational: low P I C O Outcome Outcome Outcome Outcome Evidence synthesis Critical Critical Important Not Summary of findings & estimate of effect for each outcome High Moderate Low Very low 1. Risk of bias 2. Inconsistency 3. Indirectness 4. Imprecision 5. Publication bias 1. Large effect 2. Dose response 3. Opposing bias & Confounders Recommendation Grade recommendations (Evidence to Recommendation) For or against (direction) Strong or conditional/weak (strength) By considering balance of consequences (evidence to recommendations): Quality of evidence Balance benefits/harms Values and preferences Feasibility, equity and acceptability Resource use (if applicable) Guideline Grade overall quality of evidence across outcomes based on lowest quality of critical outcomes Formulate Recommendations ( ) The panel recommends that.should... The panel suggests that.should... The panel suggests to not... The panel recommends to not... Transparency, clear, actionable Research?

longer life fewer symptoms fewer complications better quality of life sensitivity specificity

Why is this relevant for COMET Summary of Findings Tables report information for patient or population important outcomes Outcomes are determined by decisionmakers (e.g. panels): over and over again But we wouldn t have to (if there was a core outcome set)

In summary SoF tables improve systematic review users understanding and rapidity of grasping information Study showed this was using suboptimal formats big improvement in formats with testing There is no one results presentation that fits all potential users need interactive SoF SoFs are essential and should be compulsory

Contact Holger.Schunemann@McMaster.ca @schunemann_mac